Sheeba Irshad

11PUBLICATIONS
140CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 21, 2026
Immunodominant Antiviral T Cell Responses Outcompete Antitumor T Cell Responses to Reduce the Efficacy of Oncolytic Viroimmunotherapy.

|Aug 26, 2026
Cancer Immunotherapy Using AIRE Conditioning of the Tumor Epitopeome.

|Apr 28, 2026
A Randomized, Phase II Clinical Trial of FLT-PET and FDG-PET for Early Response Assessment of Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.

|Oct 23, 2025
An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer.

Alicia M Chenoweth, Anthony Cheung, Jitesh Chauhan

|Aug 18, 2025
The functional and therapeutic potential of epitranscriptomics in breast cancer.

Rachel L Thompson, Jennifer Lothion-Roy, Eleanor Bellows

|Dec 12, 2024
CXCL12-Targeted Immunomodulatory Gene Therapy Reduces Radiation-Induced Fibrosis in Healthy Tissues.

James T Paget, Joseph A Ward, Andrew R McKean

Pageof 2

Frequent Collaborators

5 joint publications

Alan Melcher

5 joint publications

Andrew Tutt

4 joint publications

Syed Haider

4 joint publications

Anita Grigoriadis